Peer Review, UGC Care
RELATIONSHIP OF HS-CRP LEVEL IN DIABETIC PERSONS FREE FROM MICRO AND MACROVASCULAR DISEASE
View PDF

Keywords

BMI, Diabetic, Hs-crp, vascular complication.

How to Cite

Bhaktha, G. ., Shantaram, M. ., Nayak, S. ., & Nagendra S. (2014). RELATIONSHIP OF HS-CRP LEVEL IN DIABETIC PERSONS FREE FROM MICRO AND MACROVASCULAR DISEASE. International Journal of Research and Development in Pharmacy & Life Sciences, 3(4), 1070-1073. Retrieved from https://ijrdpl.com/index.php/ijrdpl/article/view/359

Abstract

C-reactive protein is considered as one of the most sensitive markers of systemic inflammation. Studies have found that increase in the levels of C- reactive protein is associated with the vascular complications.

Hence we aimed in finding the correlation of hs-crp with other risk factors like BMI, FBS and HbA1c in diabetic subjects who have still not developed any micro and macrovascular complications. 229 cases of type 2 diabetics and 205 healthy individuals were selected as per the criteria. BMI was calculated, FBS was estimated by glucose-oxidase peroxidase method. Hs-crp was estimated by immunoturbidometric technique. The group was divided into low risk and high risk group as per their hs-crp level. Correlation was seen with other factors like BMI, FBS and HbA1c. The level of Hs-crp was high in diabetic subjects when compared to normal individuals. Further when the diabetic subjects were divided into high risk and low risk groups, the difference between the groups were statistically significant. Hs-crp failed to show any correlation with BMI, FBS and HbA1c. Diabetes is considered as an inflammatory disease hence we observed an increase in the hs-crp level in diabetes than in the normal. Since the vascular complication was totally absent hs-crp failed to show any correlation with BMI, FBS and HbA1c.

View PDF

References

Taylor AW, Ku NO, Mortensen RF. (1990) Journal of Immunology .145: 2507-2513.

Pepys MB, Hirschfield GM. (2003) Journal of Clinical Investigation .111: 1805–1812.

Black S, Kushner I, Samols D. (2004) Journal of Biological Chemistry .279: 48487- 48490.

Sun H, Koike T, Ichikawa T. ( 2005) American Journal of Pathology.167 : 1139–1148.

Blake GJ, Ridker PM. (2003)Journal of the American College of Cardiology .41 : 37–42.

Ridker PM, Bassuk SS , Toth PP.( 2003) Current Atherosclerosis Reports.5 : 341–349.

Martha RM, Fernando GR. (1999) Journal of Diabetes and its complications.13: 211-215.

Turner RC, Millns H, Neil HA, Stratton IM, Manley SE, Matthews DR. (1998) BMJ .316: 823-8.

Cosin Aguilar J, Hernandiz. Martinez A. (2007) The CORONARIA STUDY. Med clin ( Barc).10:129.

Geiss L.S., Rolka DB, Engelagau MM. (2002) AMJ Prev Med.22: 42-48.

Ni Mhurchu C, Parag V, Nakamara M. (2006) Asia Pac. J. Clin. Nutr .15(2): 127-133.

NHANES. (2005) JAMA.293: 546-547.

Li CZ, Xue YM, Gao F, Wang M. (2004) Di Yi Jhun Yi Da Xne Xne Bao.24: 791-793.

Rodriguez MM, Guerrero R F. (1993) J Endocrinol. Invest..26: 216-221.

Barinas M E, Cushman M, Meilan EN, Tracy RP, Kuller LH. (2001) Am. J Epidemiol. : 1094-1101.

Frohlich M, Imhof A, Berg G. (2000) Diabetic Care. .23: 1835- 1839.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

Copyright (c) 2020 Array

Downloads

Download data is not yet available.